Exact Sciences to Present Late-Breaking Data from Pivotal BLUE-C Study on Next-Generation Cologuard at ACG 2023 - Exact Sciences (NASDAQ:EXAS)
MADISON, Wis., Oct. 9, 2023 /PRNewswire/ -- Exact Sciences Corp. (NASDAQ:EXAS), a leading provider of cancer screening and diagnostic tests, today announced the company will present late-breaking data on next-generation
United States British Columbia Thomasf Imperiale Paul Limburg Derekw Ebner Indiana University School Of Medicine
Source: benzinga.com